Mutation based approaches to the treatment of anaplastic thyroid cancer.
Hilary C McCraryJoni AokiYiqing HuangBarbara ChadwickKatie KerriganBenjamin WittJason P HuntDev AbrahamPublished in: Clinical endocrinology (2022)
The integration of early genomic analysis and personalized neoadjuvant TKI therapy into the treatment of ATC can greatly benefit patient care outcomes and optimize tumour control.